Lead identification of conformationally restricted benzoxepin type combretastatin analogs: Synthesis, antiproliferative activity, and tubulin effects

18Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We have synthesized a series of polymethoxylated rigid analogs of combretastatin A-4 which contain a benzoxepin ring in place of the usual ethylene bridge present in the natural combretastatin products. The compounds display antiproliferative activity when evaluated against the MCF-7 and MDA human breast carcinoma cell lines. 5-(3-Hydroxy-4-methoxyphenyl)-4-(3,4,5- trimethoxyphenyl)-2,3-dihydro-benzoxepine (11g) was found to be the most potent product when evaluated against the MCF-7 breast cancer cell line. A brief computational study of the structureactivity relationship for the synthesized compounds is presented. These 4,5-diarylbenzoxepins are identified as potentially useful scaffolds for the further development of antitumor agents which target tubulin. © 2010 Informa UK Ltd.

Cite

CITATION STYLE

APA

Barrett, I., Carr, M., O’Boyle, N., Greene, L. M., J. S. Knox, A., Lloyd, D. G., … Meegan, M. J. (2010). Lead identification of conformationally restricted benzoxepin type combretastatin analogs: Synthesis, antiproliferative activity, and tubulin effects. In Journal of Enzyme Inhibition and Medicinal Chemistry (Vol. 25, pp. 180–194). https://doi.org/10.3109/14756360903169659

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free